Third Rock seeds cell therapy startup with $95M in bid to cure MS
In 2018, former Biogen executives Samantha Singer and Richard Ransohoff were working with Third Rock on a new way to treat autoimmune diseases when one …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
